Table 6.
Patient outcomes by induction agent in patients with ISS > 16 (n = 664)
Outcome | Induction agent | p-value | ||
---|---|---|---|---|
Ketamine vs. etomidate | Ketamine vs. propofol | Etomidate vs. propofol | ||
In-hospital mortality | 1.6 (0.8, 3.1) | 4.3 (1.1, 16.5)* | 6.8 (1.8, 25.3)* | 0.003 |
Hypotension 24 h post intubation | 1.0 (0.5, 1.9) | 0.8 (0.4, 1.7) | 0.8 (0.4, 1.7) | 0.78 |
Vasopressor requirement 24 h post intubation | 0.5 (0.3, 0.9)* | 1.7 (0.8, 3.9) | 0.8 (0.4, 2.0) | 0.067 |
Complication | 1.6 (0.8, 3.2) | 1.7 (0.8, 3.7) | 2.8 (1.2, 6.4)* | 0.056 |
Discharged home with/without services | 1.3 (0.6, 2.7) | 1.0 (0.4, 2.2) | 1.2 (0.5, 3.0) | 0.78 |
Estimates represents OR (95% CI). All models are adjusted for hospital site, age, revised trauma score (RTS), traumatic brain injury (TBI), and intubation location
*Significantly different at a Bonferroni-adjusted p < 0.05